Thursday, April 07, 2022 8:29:06 AM
There are at least 3 things I can't help you with in your post.
1. Acquisition nonsense?
2. Nice looking bottles?
3. 3rd world countries?
There are 4 PR's that talk about this acquisition, and 2 filings. What we all invested in last year was already known, there was no talk of nice looking bottles then. SHMN business description has always been largely about selling to "developing" countries. Now we don't like them because they are selling to Africa?
7 MM's yesterday at .0015.
Respects. Hl. Shmn
1. Acquisition nonsense?
2. Nice looking bottles?
3. 3rd world countries?
There are 4 PR's that talk about this acquisition, and 2 filings. What we all invested in last year was already known, there was no talk of nice looking bottles then. SHMN business description has always been largely about selling to "developing" countries. Now we don't like them because they are selling to Africa?
7 MM's yesterday at .0015.
Respects. Hl. Shmn
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
